Michael Heuser


Ontology type: schema:Person     


Person Info

NAME

Michael

SURNAME

Heuser

Publications in SciGraph latest 50 shown

  • 2022-09-19 Diagnostik bei unklaren Zytopenien – wie und wann suchen wir nach klonaler Hämatopoese? in DIE INNERE MEDIZIN
  • 2022-08-16 Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial in LEUKEMIA
  • 2022-08-03 Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial in LEUKEMIA
  • 2021-11-02 Correction: Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia in LEUKEMIA
  • 2021-10-04 Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia in BLOOD CANCER JOURNAL
  • 2021-07-28 Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results in LEUKEMIA
  • 2021-05-12 Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial in ANNALS OF HEMATOLOGY
  • 2021-03-23 Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis? in CLINICAL & EXPERIMENTAL METASTASIS
  • 2021-03-19 Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial in ANNALS OF HEMATOLOGY
  • 2021-02-12 Therapierefraktäre Anämie bei einem 35-jährigen Dialysepatienten nach Herztransplantation in DER INTERNIST
  • 2021-01-28 Germline variants drive myelodysplastic syndrome in young adults in LEUKEMIA
  • 2020-10-27 Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow in ANNALS OF HEMATOLOGY
  • 2020-09-18 IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis in LEUKEMIA
  • 2020-07-30 Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results in LEUKEMIA
  • 2020-07-23 Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up in ANNALS OF HEMATOLOGY
  • 2020-07-14 Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2020-06-24 Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia in LEUKEMIA
  • 2020-04-15 Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2020-03-16 Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study in LEUKEMIA
  • 2019-10-22 Diagnostik und Management des myelodysplastischen Syndroms in DIE ONKOLOGIE
  • 2019-10-18 Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2019-10-04 In vivo efficacy of mutant IDH1 inhibitor HMS-101 and structural resolution of distinct binding site in LEUKEMIA
  • 2019-08-28 Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML) in LEUKEMIA
  • 2019-05-18 Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo in ANNALS OF HEMATOLOGY
  • 2019-05-02 Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation in NATURE COMMUNICATIONS
  • 2019-02-06 Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine in LEUKEMIA
  • 2019-01-11 KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis in LEUKEMIA
  • 2018-12-16 Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome in LEUKEMIA
  • 2018-12-13 Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia in LEUKEMIA
  • 2018-09-03 Mögliche neue Therapiestrategien bei B‑Zell-Lymphomen in DER INTERNIST
  • 2018-06-16 Personalisierte Medizin in der Hämatoonkologie in INFO HÄMATOLOGIE + ONKOLOGIE
  • 2018-06-15 ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF in LEUKEMIA
  • 2018-05-31 Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option in ONCOGENE
  • 2018-04-17 Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial in LEUKEMIA
  • 2018-02-14 Publisher Correction: Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection in NATURE IMMUNOLOGY
  • 2017-10-31 Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO) in ANNALS OF HEMATOLOGY
  • 2017-09-29 Meis2 as a critical player in MN1-induced leukemia in BLOOD CANCER JOURNAL
  • 2017-08-22 RNA interference efficiently targets human leukemia driven by a fusion oncogene in vivo in LEUKEMIA
  • 2017-06-13 Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation in ANNALS OF HEMATOLOGY
  • 2017-06-02 Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia in LEUKEMIA
  • 2017-04-12 IDH-Inhibitoren in DIE ONKOLOGIE
  • 2017-03-22 The hypomorphic TERT A1062T variant is associated with increased treatment-related toxicity in acute myeloid leukemia in ANNALS OF HEMATOLOGY
  • 2017-02-20 Human γδ T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection in NATURE IMMUNOLOGY
  • 2017-01-31 Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo in LEUKEMIA
  • 2017-01-19 Impact of salvage regimens on response and overall survival in acute myeloid leukemia with induction failure in LEUKEMIA
  • 2017-01-18 Impact of pretreatment characteristics and salvage strategy on outcome in patients with relapsed acute myeloid leukemia in LEUKEMIA
  • 2017-01-16 Incidence and prognostic impact of ASXL2 mutations in adult acute myeloid leukemia patients with t(8;21)(q22;q22): a study of the German-Austrian AML Study Group in LEUKEMIA
  • 2017-01-16 Precision oncology for acute myeloid leukemia using a knowledge bank approach in NATURE GENETICS
  • 2016-12-09 MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia in BLOOD CANCER JOURNAL
  • 2016-11-24 Acute myeloid leukemia derived from lympho-myeloid clonal hematopoiesis in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.10423.34", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419801.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412811.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10392.39", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7497.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.500061.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.33018.39", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7708.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.13648.38", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410712.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5802.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411778.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5963.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.26999.3d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.469999.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.248762.d", 
            "type": "Organization"
          }
        ], 
        "familyName": "Heuser", 
        "givenName": "Michael", 
        "id": "sg:person.0716104605.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716104605.17"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-10-01T07:17", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/person/person_706.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0716104605.17'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0716104605.17'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0716104605.17'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0716104605.17'


     

    This table displays all metadata directly associated to this object as RDF triples.

    46 TRIPLES      10 PREDICATES      26 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0716104605.17 schema:affiliation N988d3b52ad6b4051ac1603f6da34d7b5
    2 grid-institutes:grid.10392.39
    3 grid-institutes:grid.13648.38
    4 grid-institutes:grid.248762.d
    5 grid-institutes:grid.26999.3d
    6 grid-institutes:grid.33018.39
    7 grid-institutes:grid.410712.1
    8 grid-institutes:grid.411778.c
    9 grid-institutes:grid.412811.f
    10 grid-institutes:grid.419801.5
    11 grid-institutes:grid.469999.2
    12 grid-institutes:grid.500061.2
    13 grid-institutes:grid.5802.f
    14 grid-institutes:grid.5963.9
    15 grid-institutes:grid.7497.d
    16 grid-institutes:grid.7708.8
    17 schema:familyName Heuser
    18 schema:givenName Michael
    19 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716104605.17
    20 schema:sdDatePublished 2022-10-01T07:17
    21 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    22 schema:sdPublisher Nd5fac132673040d4be132fd09297ddc6
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset persons
    25 rdf:type schema:Person
    26 N988d3b52ad6b4051ac1603f6da34d7b5 schema:affiliation grid-institutes:grid.10423.34
    27 sgo:isCurrent true
    28 rdf:type schema:OrganizationRole
    29 Nd5fac132673040d4be132fd09297ddc6 schema:name Springer Nature - SN SciGraph project
    30 rdf:type schema:Organization
    31 grid-institutes:grid.10392.39 schema:Organization
    32 grid-institutes:grid.10423.34 schema:Organization
    33 grid-institutes:grid.13648.38 schema:Organization
    34 grid-institutes:grid.248762.d schema:Organization
    35 grid-institutes:grid.26999.3d schema:Organization
    36 grid-institutes:grid.33018.39 schema:Organization
    37 grid-institutes:grid.410712.1 schema:Organization
    38 grid-institutes:grid.411778.c schema:Organization
    39 grid-institutes:grid.412811.f schema:Organization
    40 grid-institutes:grid.419801.5 schema:Organization
    41 grid-institutes:grid.469999.2 schema:Organization
    42 grid-institutes:grid.500061.2 schema:Organization
    43 grid-institutes:grid.5802.f schema:Organization
    44 grid-institutes:grid.5963.9 schema:Organization
    45 grid-institutes:grid.7497.d schema:Organization
    46 grid-institutes:grid.7708.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...